- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Immune Evasion in Melanoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 8984
Publisher
MDPI AG
Online
2020-11-26
DOI
10.3390/ijms21238984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
- (2020) David E. Elder et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Systemic Antitumor Effects and Abscopal Responses in Melanoma Patients Receiving Radiation Therapy
- (2020) Mark A. D’Andrea et al. ONCOLOGY
- Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells
- (2020) Priyanka Sharma et al. Scientific Reports
- CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
- (2020) Christina Friese et al. Scientific Reports
- Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
- (2020) Ioana Plesca et al. Frontiers in Immunology
- Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA)
- (2020) Dennis Gerloff et al. Cancers
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Sex-associated molecular differences for cancer immunotherapy
- (2020) Youqiong Ye et al. Nature Communications
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
- (2020) Aline Pfefferle et al. Cancers
- Long-Term Follow-Up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients With Advanced Melanoma: KEYNOTE-029 Part 1B
- (2020) Matteo S. Carlino et al. CLINICAL CANCER RESEARCH
- Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab
- (2020) Maria Pia Pistillo et al. CLINICAL IMMUNOLOGY
- Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry
- (2020) Kai Huang et al. JOURNAL OF SURGICAL RESEARCH
- Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Ralf Gutzmer et al. LANCET
- Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
- (2020) Anders Handrup Kverneland et al. Oncotarget
- Efficacy of immune checkpoint inhibitors in different types of melanoma
- (2020) Ernesto Rossi et al. Human Vaccines & Immunotherapeutics
- Ultraviolet Radiation and Melanomagenesis: From Mechanism to Immunotherapy
- (2020) Xiaoying Sun et al. Frontiers in Oncology
- The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
- (2020) Floris Dammeijer et al. CANCER CELL
- Strength of immune selection in tumors varies with sex and age
- (2020) Andrea Castro et al. Nature Communications
- Liver damage related to immune checkpoint inhibitors
- (2019) Naoshi Nishida et al. Hepatology International
- Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
- (2019) Hyun Lee et al. MOLECULES
- Efficacy and safety of ipilimumab for treating advanced melanoma: A systematic review and meta-analysis
- (2019) Jing Li et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis
- (2019) Bin Hou et al. DISEASE MARKERS
- Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ Melanoma
- (2019) Raj Shah et al. CANCER RESEARCH
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
- (2019) Marine Leclerc et al. Nature Communications
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
- (2019) Ernesto Rossi et al. Cancers
- Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance
- (2019) Markus Düchler et al. Cells
- Current state of melanoma diagnosis and treatment
- (2019) Lauren E. Davis et al. CANCER BIOLOGY & THERAPY
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
- (2019) Yochai Wolf et al. CELL
- IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
- (2019) Alexander Thiem et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
- (2019) Lewis Zhichang Shi et al. Cancer Immunology Research
- Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size
- (2019) Sabran J. Masoud et al. ANNALS OF SURGICAL ONCOLOGY
- Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
- (2019) Spencer C. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
- (2019) Annika De Sousa Linhares et al. Scientific Reports
- The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
- (2019) Weiting Qin et al. Frontiers in Immunology
- Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
- (2019) Marco Tucci et al. Frontiers in Oncology
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- (2019) David Liu et al. NATURE MEDICINE
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- (2018) Frederick Arce Vargas et al. CANCER CELL
- PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
- (2018) Tricia R. Cottrell et al. CANCER JOURNAL
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- Melanoma exosomes promote mixed M1 and M2 macrophage polarization
- (2018) Gina T. Bardi et al. CYTOKINE
- Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features
- (2018) Ki Rang Moon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
- (2018) Ioannis Zerdes et al. ONCOGENE
- Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis
- (2018) Prue H. Hart et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Anti–CTLA-4 therapy requires an Fc domain for efficacy
- (2018) Jessica R. Ingram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials
- (2018) Alberto Carretero-González et al. Oncotarget
- Prospects of IL-2 in Cancer Immunotherapy
- (2018) Hani Choudhry et al. Biomed Research International
- Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
- (2018) Christopher A Natale et al. eLife
- Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
- (2018) Genevieve P Hartley et al. Cancer Immunology Research
- Double agents: genes with both oncogenic and tumor-suppressor functions
- (2018) Libing Shen et al. Oncogenesis
- Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study
- (2018) Ethan M. Shevach Frontiers in Immunology
- MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project
- (2018) Elena Tagliabue et al. Cancer Management and Research
- Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
- (2018) Carole Achard et al. EBioMedicine
- Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
- (2018) Taku Fujimura et al. Frontiers in Oncology
- Biomarkers for Immune Checkpoint Inhibitors in Melanoma
- (2018) Shigehisa Kitano et al. Frontiers in Oncology
- Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
- (2018) Jun Zhang et al. Frontiers in Oncology
- Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
- (2018) Maria Pia Pistillo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities
- (2018) Roy Rabbie et al. JOURNAL OF PATHOLOGY
- Predictors of mucosal melanoma survival in a population-based setting
- (2018) Lisa Altieri et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of primary cutaneous melanoma
- (2018) Susan M. Swetter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
- (2018) Satu Salmi et al. MELANOMA RESEARCH
- Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types
- (2018) Angela M. Magnuson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study
- (2018) Dongxiao Zhang et al. Cancer Management and Research
- Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
- (2018) Maartje W. Rohaan et al. Journal for ImmunoTherapy of Cancer
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma
- (2017) Winnie S. Liang et al. GENOME RESEARCH
- M1 Means Kill; M2 Means Heal
- (2017) Klaus Ley JOURNAL OF IMMUNOLOGY
- Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
- (2017) Eleni Vergadi et al. JOURNAL OF IMMUNOLOGY
- Transcriptional and epigenetic regulation of T cell hyporesponsiveness
- (2017) Renata M. Pereira et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
- (2017) Jennifer D. Hintzsche et al. MELANOMA RESEARCH
- M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
- (2017) Monica Falleni et al. MELANOMA RESEARCH
- Quantitative Mass Spectrometry Analysis of PD-L1 Protein Expression,N-glycosylation and Expression Stoichiometry with PD-1 and PD-L2 in Human Melanoma
- (2017) Carlos A. Morales-Betanzos et al. MOLECULAR & CELLULAR PROTEOMICS
- Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
- (2017) Christina M. Maher et al. MOLECULAR CANCER RESEARCH
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loci associated with skin pigmentation identified in African populations
- (2017) Nicholas G. Crawford et al. SCIENCE
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival
- (2017) Konrad Buscher et al. Nature Communications
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness
- (2017) Allison L. Isola et al. Oncotarget
- Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies
- (2017) Mengnan He et al. Oncotarget
- PD1 signal transduction pathways in T cells
- (2017) Hugo Arasanz et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Pro-tumor activities of macrophages in the progression of melanoma
- (2017) Huafeng Wang et al. Human Vaccines & Immunotherapeutics
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
- (2017) Jun Zhou et al. Cancer Immunology Research
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
- (2017) Rossana Tallerico et al. OncoImmunology
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma
- (2016) Jared Klarquist et al. CANCER RESEARCH
- Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
- (2016) Curtis A. Clark et al. CANCER RESEARCH
- Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
- (2016) Benjamin Weide et al. CLINICAL CANCER RESEARCH
- GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis
- (2016) Xinan Sheng et al. EUROPEAN JOURNAL OF CANCER
- Uveal melanoma: relatively rare but deadly cancer
- (2016) S Kaliki et al. EYE
- Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation
- (2016) Stanley Ching-Cheng Huang et al. IMMUNITY
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3+T Cell Subpopulations
- (2016) Hiroko Fujii et al. JOURNAL OF IMMUNOLOGY
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas
- (2016) Vinicius de Lima Vazquez et al. MELANOMA RESEARCH
- Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma
- (2016) Elizabeth Ann L. Enninga et al. MELANOMA RESEARCH
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
- (2016) Amanda R Moore et al. NATURE GENETICS
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
- (2016) Deborah Kuk et al. ONCOLOGIST
- Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
- (2016) Sumit K. Subudhi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
- (2016) Katrin Klocke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors
- (2016) Christopher A Natale et al. eLife
- PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome
- (2016) Joseph M. Obeid et al. OncoImmunology
- Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma
- (2016) Allison Isola et al. Cancers
- Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets
- (2016) Laurent Muller et al. Scientific Reports
- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
- (2015) E. Van Overmeire et al. CANCER RESEARCH
- Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity
- (2015) Marco Donia et al. CANCER RESEARCH
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Suppression of antigen presentation by IL-10
- (2015) Sharad K Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- The use of interferon in melanoma patients: A systematic review
- (2015) Rossella Di Trolio et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The melanocyte lineage in development and disease
- (2015) R. L. Mort et al. DEVELOPMENT
- Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
- (2015) Zeynep Eroglu et al. EUROPEAN JOURNAL OF CANCER
- Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up
- (2015) Fan Liu et al. HUMAN GENETICS
- Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
- (2015) Chien-Chung Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma
- (2015) Christina Dahl et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- KIT in Melanoma: Many Shades of Gray
- (2015) Ana Slipicevic et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Impaired gp100-Specific CD8 + T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model
- (2015) David G. Mairhofer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor
- (2015) Connull Leslie et al. PATHOLOGY
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Update on Immunotherapy in Melanoma
- (2015) Jamie Green et al. Surgical Oncology Clinics of North America
- PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
- (2015) Nikolaos Patsoukis et al. Nature Communications
- Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
- (2015) Peter Johansson et al. Oncotarget
- Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
- (2015) Zeynep Eroglu et al. Therapeutic Advances in Medical Oncology
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Pathways and therapeutic targets in melanoma
- (2015) Emma Shtivelman et al. Oncotarget
- Nevus-Associated Melanomas
- (2014) Danielle Shitara et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
- (2014) Vassiliki A. Boussiotis et al. CANCER JOURNAL
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
- (2014) M. Atefi et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells in malignant melanoma
- (2014) Viktor Umansky et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival
- (2014) W. N. D'Souza et al. JOURNAL OF IMMUNOLOGY
- Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
- (2014) Rituparna Das et al. JOURNAL OF IMMUNOLOGY
- Magnetic resonance imaging of melanoma exosomes in lymph nodes
- (2014) Lingzhi Hu et al. MAGNETIC RESONANCE IN MEDICINE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
- (2014) Jason Madore et al. Pigment Cell & Melanoma Research
- The melanoma revolution: From UV carcinogenesis to a new era in therapeutics
- (2014) J. A. Lo et al. SCIENCE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
- (2014) P. Kvistborg et al. Science Translational Medicine
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- Is the scavenger receptor MARCO a new immune checkpoint?
- (2014) Mohamed S Arredouani OncoImmunology
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
- (2013) D. Laoui et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- Immunotherapy of melanoma
- (2013) John B.A.G. Haanen EJC SUPPLEMENTS
- Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity
- (2013) Kellie A. Mouchemore et al. FEBS Journal
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways
- (2013) Patrick L. Raber et al. INTERNATIONAL JOURNAL OF CANCER
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
- (2013) Paolo A. Ascierto et al. JOURNAL OF CLINICAL ONCOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antigen-Specific Induced T Regulatory Cells Impair Dendritic Cell Function via an IL-10/MARCH1-Dependent Mechanism
- (2013) G. Chattopadhyay et al. JOURNAL OF IMMUNOLOGY
- Melanoma prone families withCDK4germline mutation: phenotypic profile and associations withMC1Rvariants
- (2013) Hanne Eknes Puntervoll et al. JOURNAL OF MEDICAL GENETICS
- Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma
- (2013) Simon J Furney et al. JOURNAL OF PATHOLOGY
- Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma
- (2013) Wonjin Chang et al. MELANOMA RESEARCH
- PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2
- (2013) Nikolaos Patsoukis et al. MOLECULAR AND CELLULAR BIOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- A Clinicopathologic Analysis of 177 Acral Melanomas in Koreans
- (2013) Ho Joo Jung et al. JAMA Dermatology
- Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy
- (2013) D. Ng Tang et al. Cancer Immunology Research
- Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models
- (2012) J. H. Shin et al. BLOOD
- Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
- (2012) Miriam Alb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Surgery for Distant Melanoma Metastasis
- (2012) Anna M. Leung et al. CANCER JOURNAL
- BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
- (2012) Richard C. Koya et al. CANCER RESEARCH
- Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
- (2012) J. S. Khalili et al. CLINICAL CANCER RESEARCH
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
- (2012) A. M. Menzies et al. CLINICAL CANCER RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases
- (2012) Susanne Schiffner et al. EXPERIMENTAL DERMATOLOGY
- M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles
- (2012) Martina C. Herwig et al. EXPERIMENTAL EYE RESEARCH
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
- (2012) E. Schlecker et al. JOURNAL OF IMMUNOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- Functional Effects of GRM1 Suppression in Human Melanoma Cells
- (2012) J. Wangari-Talbot et al. MOLECULAR CANCER RESEARCH
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glutamatergic signaling in cellular transformation
- (2012) Jessica L. F. Teh et al. Pigment Cell & Melanoma Research
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Tumor-Infiltrating Lymphocytes in Melanoma
- (2012) Sylvia Lee et al. Current Oncology Reports
- B7-H1 limits the entry of effector CD8+T cells to the memory pool by upregulating Bim
- (2012) Rachel M Gibbons et al. OncoImmunology
- CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation
- (2011) Xiong B Wang et al. BMC IMMUNOLOGY
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
- (2011) J. L. Hood et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
- (2011) Asis Palazón et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner
- (2011) P. Chen et al. CLINICAL CANCER RESEARCH
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
- (2011) John F. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod
- (2011) Elizabeth C. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006
- (2011) Xiao-Cheng Wu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence
- (2011) Eijun Itakura et al. MODERN PATHOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4+CD25+ Regulatory T Cells
- (2011) Haley Ataera et al. PLoS One
- T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells
- (2011) K. Adachi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
- (2010) W. Hobo et al. BLOOD
- Adoptive Cell Therapy
- (2010) Richard A. Morgan et al. CANCER JOURNAL
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
- (2010) K. Movahedi et al. CANCER RESEARCH
- Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
- (2010) B. C. Carthon et al. CLINICAL CANCER RESEARCH
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions
- (2010) Stefania Laurent et al. HUMAN IMMUNOLOGY
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Langerhans Cells Are Required for UVR-Induced Immunosuppression
- (2010) Agatha Schwarz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032
- (2010) Jonas N Søndergaard et al. Journal of Translational Medicine
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF
- (2010) Michael Quigley et al. NATURE MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma
- (2010) Andrea Ladányi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Role of radiotherapy in melanoma management
- (2010) Primoz Strojan Radiology and Oncology
- Surgery of Primary Melanomas
- (2010) Piotr Rutkowski et al. Cancers
- Decoding Melanoma Metastasis
- (2010) William E. Damsky et al. Cancers
- Acral Lentiginous Melanoma
- (2009) Porcia T. Bradford et al. ARCHIVES OF DERMATOLOGY
- Tanning and Increased Nevus Development in Very-Light-Skinned Children Without Red Hair
- (2009) Jenny Aalborg et al. ARCHIVES OF DERMATOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
- (2009) W. K. Nevala et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Molecular genetics of human pigmentation diversity
- (2009) R. A. Sturm HUMAN MOLECULAR GENETICS
- Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma
- (2009) Trine O. Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis
- (2009) Kristin Turza et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
- (2009) Seung-Shick Shin et al. Pigment Cell & Melanoma Research
- Review: Therapeutic opportunities in noncutaneous melanoma
- (2009) D.K. Wilkins et al. Therapeutic Advances in Medical Oncology
- FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions
- (2008) M. Ahmadzadeh et al. BLOOD
- Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
- (2008) Patrizia Stoitzner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemotherapy Induces Tumor Clearance Independent of Apoptosis
- (2008) J. L. Guerriero et al. CANCER RESEARCH
- Death through a tragedy: mitotic catastrophe
- (2008) H Vakifahmetoglu et al. CELL DEATH AND DIFFERENTIATION
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Induction of myeloid-derived suppressor cells by tumor exosomes
- (2008) Xiaoyu Xiang et al. INTERNATIONAL JOURNAL OF CANCER
- Transient T cell depletion causes regression of melanoma metastases
- (2008) Mary Rasku et al. Journal of Translational Medicine
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma
- (2008) Y Ohtani et al. ONCOGENE
- Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation
- (2008) Seung-Shick Shin et al. Pigment Cell & Melanoma Research
- CTLA-4 blockade increases IFN -producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
- (2008) C. I. Liakou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started